Our core values: Integrity, Excellence, Respect, Teamwork, Trust

Artizan Biosciences, Inc. is a biotechnology company with a mission to restore lives disrupted by inflammatory disease through innovation and advancement of microbiota-targeted therapies. We are leveraging our proprietary IgA-SEQ™ technology platform to distinguish disease-driving bacteria from the intestinal microbiota with the goal of developing new and potentially curative treatments.

Founders

  • Richard A. Flavell

    Richard A. Flavell, Ph.D., D.Sc., FRS

  • Noah Palm

    Noah W. Palm, Ph.D.

  • Marcel de Zoete

    Marcel R. de Zoete, Ph.D.

Team

  • Jordan Bendor, B.S., Research Associate II

  • Priyanka Chintha, M.S., Scientist II

  • Chase Fredrick, M.S., Research Associate

  • Kaelan Hayes, M.H.S., Research Associate

  • Paul F. Miller, Ph.D., Chief Scientific Officer

  • Edward Natoli, M.A., Senior Scientist

  • James H. Rosen, M.B.A., M.S.P.H., President & Chief Executive Officer

  • Stacy Hyunji Ryu, Ph.D., Director, Mechanistic Research

  • Whitman B. Schofield, Ph.D., Director II, Preclinical Biology

  • Keely Walsh, B.S., L.A.T.G., Research Scientist I, Preclinical

Board

  • Christy Shaffer

    Christy Shaffer, Ph.D.

  • Moncef Slaoui

    Moncef Slaoui, Ph.D.

  • Marian Nakada

    Marian Nakada, Ph.D.

  • Jon Soderstrom

    Jon Soderstrom, Ph.D.

  • Holden Thorpe

    Holden Thorp, Ph.D.

  • James H. Rosen

    James Rosen, M.B.A., M.S.P.H. President & Chief Executive Officer

Contact Us

Artizan Biosciences, Inc.
25 Science Park at Yale
150 Munson St; Suite 210
New Haven, CT 06511

Send us a message.